cannabis stocks

Investors retreat after Canopy Growth Corp. reports $1.3-billion annual loss

Canopy’s financial woes haven’t helped the share prices of other Canadian licensed weed producers.


Cannabis stocks soar—and New York tabloid ties this to study on COVID-19 prevention

The market capitalizations of Aurora, Tilray, Canopy Growth, Aphria, Cronos Group, and Hexo are all sharply higher than they were seven days earlier.


Aurora Cannabis shares spike in early trading following Reliva CBD takeover

Earlier this month, one financial writer described the company as the poster child of the legal weed industry’s woes.

No Image

Aurora Cannabis shares shoot up on positive quarterly numbers

Our roundup of cannabis stocks shows some improvement for Canopy Growth Corporation after a shakeup in the corporate office, but it was humdrum week for Tilray, Cronos Group, and Aphria.


Tilray doubles sales in first quarter over same period in 2019

The Canadian cannabis producer’s net loss also increased substantially


Cronos Group CEO Mike Gorenstein says company remains agile despite challenges posed by COVID-19

It was a mixed week for investors in Canadian cannabis companies